Approval · Notice of Compliance 19123 · 2017
UTROGESTAN: Notice of Compliance 19123
Issued April 5, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19123
- Date
- April 5, 2017
- Company
- Besins Healthcare S A
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| UTROGESTAN | 02462818 | Approved |
Medicinal ingredients
- PROGESTERONE 200 MG per CAP